Literature DB >> 20657429

An expeditious synthesis of [1,2]isoxazolidin-5-ones and [1,2]oxazin-6-ones from functional allyl bromide derivatives.

Imen Beltaïef1, Aïcha Arfaoui, Hassen Amri.   

Abstract

Reaction of allyl bromide (Z)-1 and (Z)-2 with N-substituted hydroxylamine hydrochlorides in presence of tert-butoxide in tert-butanol at reflux provides a short and effective route to [1,2]isoxazolidin-5-ones 3 and [1,2]oxazin-6-ones 4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657429      PMCID: PMC6264200          DOI: 10.3390/molecules15064094

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Acrylic compounds have become highly attractive and building blocks for the synthesis of several biologically active molecules such as α-methylene-γ-butyrolactones [1,2,3,4,5] and γ-butyrolactams [6,7,8,9]. Several studies have proposed methods for the preparation of compounds bearing a α-bromomethyl moiety [10,11,12,13,14] commonly called Baylis-Hillman bromides [15,16,17,18,19]. In an ongoing project aimed at further illustrating the potential of readily prepared α-bromomethylated esters analogs 2 [9,20], we have shown the importance of functional allylic bromide 2 as an electrophilic reagent for access to pyrrolidin-2-ones [9], α-alkyl-β-carbomethoxy-γ-butyrolactams [21,22], (E,Z)-α-alkylidene-γ-butyro-lactones [23] and 4-methoxycarbonyl-1-N-alkyl-∆2-pyrrolidin-2-ones. In order to explore the potential of hydroxylamines in organic synthesis, we have been examining their nucleophilic reactivity as an N,O-centered tandem nucleophile. We report here a direct synthesis of isoxazolidin-5-ones 3 and oxazin-6-ones 4 via Michael addition then intramolecular cyclization of N-substituted hydroxylamines to functional allyl bromides ()-1 and ()-2 (Scheme 1).
Scheme 1

Synthesis of [1,2]oxazin-6-ones and [1,2]isoxazolidin-5-ones from allyl bromides 1- and 2-.

Synthesis of [1,2]oxazin-6-ones and [1,2]isoxazolidin-5-ones from allyl bromides 1- and 2-.

2. Results and Discussion

Despite the interesting potential synthetic and pharmacological value of the isoxazolidin-5-ones 3, there are only a few works in the literature reporting their synthesis [24,25]. The majority of the recorded examples have been prepared by condensation of ester enolates and their equivalents [26,27,28,29] or pyrazolidinone acrylamides [30] with N-substituted hydroxylamines. More recently, α,β-sugar lactones [31,32,33] were used as good starting Michael acceptors to produce the isoxazolidin-5-one ring system, thus providing an effective route for the selective formation of substituted azetidin-2-ones [34,35] or β-substituted-β-amino acids [36]. In order to examine the feasibility of the route outlined in Scheme 2, available allyl bromides ()-1 were prepared. Then, their condensation with a variety of N-substituted hydroxylamine hydrochlorides in the presence of potassium tert-butoxide in tert-butanol at reflux was carried out, which results in the formation of isoxazolidin-5-ones 3 in good yields, as shown in Table 1.
Scheme 2

Synthesis of (E)-4-alkylidene-2-alkylisoxazolidin-5-ones 3 from allyl bromide ()-1.

Table 1

(E)-4-Alkylidene-2-alkylisoxazolidin-5-ones 3a-e prepared.

ProductR1R2Yield a (%)
3a nC3H7tC4H960
3b C6H5tC4H983
3c nC3H7cC6H1148
3d C6H5cC6H1161
3e nC5H11cC6H1156

Isolated yield after chromatography.

Synthesis of (E)-4-alkylidene-2-alkylisoxazolidin-5-ones 3 from allyl bromide ()-1. (E)-4-Alkylidene-2-alkylisoxazolidin-5-ones 3a-e prepared. Isolated yield after chromatography. The initial reaction was considered to be, as described before in our previous work [37], a conjugated addition of the hydroxylamine amino group to the allyl bromide ()-1 leaving an ammonium intermediate which reacted with second hydroxylamine equivalent leading to an expected SN2 product followed by a reasonable transesterification (5-exo-trig process) to give (E)-4-alkylidene-2-alkylisoxazolidin-5-ones 3 as only isolated products in fair to good yields (48–83%) and with total (E)-stereoselectivity (Scheme 2, Table 1). Although this route in fact proved a successful strategy to access to the five-membered ring heterocyclic system of [1,2]isoxazolidin-5-ones 3, we considered the possibility of a more efficient and shorter sequence to generate uncommon six member structures bearing the N-O linkage, in particular [1,2]oxazin-6-ones 4. Since the [1,2]oxazine and [1,2]oxazinone skeletons have recently been found to be the central features in antitumor and antibiotic products [38,39,40], synthetic methods providing access to these skeletons have gained considerable attention [41,1,2]oxazines by using sigmatropic rearrangements and the ring-closing metathesis reaction. Tetrahedron Lett.. 2003 ">42,43,44]. To the best of our knowledge, there are only a few literature reports on this topic [1,2]-oxazinone scaffolds and [1,2]-oxazine core structures of FR900482. Tetrahedron. 2008 ">45,46,1,2]oxazines by using sigmatropicrearrangements and the ring-closing metathesis reaction. Tetrahedron Lett.. 2003 ">47]. As shown in Scheme 3, we found that the conjugate addition of N-substituted hydroxylamine hydrochlorides (3 equiv.) to dimethyl (Z)-2-(bromomethyl) fumarate (2) afforded pure [1,2]oxazin-6-ones 4 in fair to good yields.
Scheme 3

N-Substituted hydroxylamine addition to dimethyl (Z)-2-(bromomethyl) fumarate (2).

N-Substituted hydroxylamine addition to dimethyl (Z)-2-(bromomethyl) fumarate (2). Methyl 2-alkyl-6-oxo-5,6-dihydro-2H-1,2-oxazine-4-carboxylate 4a-e prepared. Isolated yield after chromatography. The synthetic approach proceeds through a two-step sequence as expected: allylic substitution (SN2’) of allyl bromide 2 by the N,O-binucleophilic reagent providing a zwitterion cyclobutane intermediate whose opening leads to the most stable (E) enaminic structure, then a spontaneous 6-exo-trig [48] cyclization process, leading to the formation of 4. Additional proof of the enaminic system in [1,2]oxazin-6-one 4a came from the 1H- and 13C-NMR data, which unequivocally showed the high and low values of the shifts of the vinylic proton at 8.04 ppm and both allylic carbon atom at 27.1 ppm, respectively. Surprisingly, the chemical yields were notably lower when N-substituted hydroxylamine moieties bearing phenyl and benzyl groups were used; this is probably due to the low solubility of the intermediary imine in the tert-butanol solvent before cyclization.

3. Experimental

3.1. General

All reactions were monitored by TLC on silica gel plates (Fluka Kieselgel 60 F254). For column chromatography, Fluka Kieselgel 70-230 mesh was used. 1H- and 13C-NMR spectra (fully decoupled) were recorded on a Bruker AMX 300 instrument in CDCl3 as solvent and with TMS as the internal standard. IR spectra were recorded with a Perkin-Elmer Paragon 1000 FT-IR spectrophotometer. Mass spectrometry was performed on an Autospec 200 Micromass instrument (Waters). Most of the reagents and solvents were obtained from commercial sources (Aldrich, Merck, Fluka) and used as received. Except for the commercially available dimethyl itaconate, allyl bromides 1 and 2 were prepared as described in references [16] and [8], respectively.

3.2. General procedure for the synthesis of (E)-4-alkylidene-2-alkylisoxazolidin-5-ones

N-Alkylhydroxylammonium chloride (30 mmol) and potassium tert-butoxide (28 mmol) in tert-butanol (45 mL) were placed in a 100 mL flask under a nitrogen atmosphere. The reaction mixture was stirred at reflux for 10 minutes then allyl bromide 1- (10 mmol) was added. After the disappearance of the substrate (TLC), the mixture was filtered under reduced pressure, evaporated and purified by chromatography on silica gel (CH2Cl2) to afford the pure 3. (E)-2-N-tert-Butyl-4-butylidene isoxazolidin-5-one (3a): Yield: 60% as a viscous yellow oil; IR (neat) 1,760, 1,645 cm-1; 1H-NMR (δ ppm, J Hz): 6.68 (m, 1H), 4.00 (s, 2H), 2.14 (m, 2H), 1.49 (m, 2H), 1.17 (s, 9H), 0.97 (t, 3H, J = 7); 13C-NMR (δ ppm): 168.9 (C=O), 139.9 (=CH), 126.8 (=C), 59.9 (C(CH3)3), 49.7 (CH2-N), 32.3 (CH2), 24.4 (CH3), 21.4 (CH2), 13.8 (CH3); MS m/z (EI) 197 (M+., 11), 182 (28), 141 (43), 57 (100), 56 (40), 44 (3), 41 (47), 29 (25); HRMS calcd. for C11H19NO2: 197.1416; found: 197.1407. (E)-4-Benzylidene-2-N-tert-butylisoxazolidin-5-one (3b): Yield: 83% as a viscous yellow oil; IR (neat) 1,730, 1,595 cm-1; 1H-NMR (δ ppm): 7.53 (m, 5H), 7.52 (s, 1H), 3.36 (s, 2H), 1.22 (s, 9H); 13C-NMR (δ ppm): 170.2 (C=O), 140.3 (=CH), 135.4 (aromatic =C), 130.1 (aromatic =CH), 128.9 (aromatic =CH), 128.1 (=C), 124.6 (aromatic =CH), 60.4 (C(CH3)3), 40.2 (NCH2), 24.5 (CH3); MS m/z (EI) 231 (M+., 14), 216 (24), 175 (49), 130 (48), 115 (64), 57 (100), 56 (45), 44 (4), 41 (53); HRMS calcd. for C14H17NO2: 231.1259; found: 231.1270. (E)-4-Butylidene-2-N-cyclohexylisoxazolidin-5-one (3c): Yield: 48% as a viscous yellow oil; IR (neat) 1,725, 1,614 cm-1; 1H-NMR (δ ppm, J Hz): 6.68 (m, 1H), 3.40 (s, 2H), 2.73 (m, 1H), 2.17 (m, 2H), 1.96 (m, 10H), 1.27 (m, 2H), 0.96 (t, 3H, J = 7.00); 13C-NMR (δ ppm): 168.9 (C=O), 140.4 (=CH), 126.2 (=C), 67.8 (NCH), 54.7 (NCH2), 31.4 (CH2), 30.8 (CH2), 27.8 (CH2), 25.8 (CH2), 24.2 (CH2), 13.9 (CH3); MS m/z (EI) 150 (69), 136 (100), 94 (29), 82 (40), 80 (45), 67 (33), 56 (39), 55 (71), 53 (34), 44 (6), 41 (71); HRMS calcd. for C13H21NO2: 223.1572; found: 223.1583.

3.3. General procedure for the synthesis of methyl 2-alkyl-6-oxo-5,6-dihydro-2H-1,2-oxazine-4-carboxylates

N-Alkylhydroxylammonium chloride (31 mmol) and potassium tert-butoxide (30 mmol) in tert-butanol (45 mL) were placed in a 100 mL flask under a nitrogen atmosphere. The reaction mixture was stirred at reflux for 10 minutes then was added 2- (10 mmol). After disappearance of the substrate (TLC), the solution was filtered under reduced pressure, evaporated and purified by chromatography on SiO2 with chloroform as an eluent to provide the pure 4. Methyl 2-N-iso-propyl-6-oxo-5,6-dihydro-2H-1,2-oxazine-4-carboxylate (4a): Yield: 79% as a yellow oil; IR (neat) 1,775, 1,730, 1,620 cm-1; 1H-NMR (δ ppm, J Hz): 8.04 (s, 1H), 4.01(m, 1H), 3.72 (s, 3H), 3.31 (s, 2H), 1.33 (d, 6H, J = 6.8); 13C-NMR (δ ppm): 171.1 (C=O), 170.5 (C=O), 149.0 (=C), 95.6 (=CH), 55.3 (CH(CH3)2), 51.8 (OCH3), 27.1 (NCH2), 19.4 (CH3); MS m/z (EI) 199 (M+., 42), 168 (1), 157 (47), 125 (33), 98 (100); HRMS calcd. for C9H13NO4: 199.0845; found: 199.0855. Methyl 2-N-tert-butyl-6-oxo-5,6-dihydro-2H-1,2-oxazine-4-carboxylate (4b): Yield: 76% as a pale yellow oil; IR (neat) 1,778, 1,740, 1,660 cm-1; 1H-NMR (δ ppm): 7.90 (s, 1H), 3.54 (s, 3H), 3.13 (s, 2H), 1.22 (s, 9H); 13C-NMR (δ ppm): 170.9 (C=O), 170.5 (C=O), 147.4 (=CH), 95.8 (=C), 61.2 (C(CH3)3), 51.7 (OCH3), 27.1 (NCH2), 26.0 (CH3); MS m/z (EI) 213 (M+., 5), 198 (1), 182 (47), 154 (3), 98 (6), 57 (100); HRMS calcd. for C10H15NO4: 213.1001; found: 213.1012. Methyl 2-N-cyclohexyl-6-oxo-5,6-dihydro-2H-1,2-oxazine-4-carboxylate (4c): Yield: 58% as a colorless oil; IR (neat) 1,757, 1,735, 1,624 cm-1; 1H-NMR (δ ppm): 8.03 (s, 1H), 3.72 (s, 3H), 3.30 (s, 2H), 2.02 (m, H), 1.53 (m, 10H); 13C-NMR (δ ppm): 170.9 (C=O), 170.7 (C=O), 148.2 (=CH), 94.4 (=C), 62.2 (NCH), 51.8 (OCH3), 29.7 (OCCH2), 27.2 (CH2), 24.8 (CH2), 24.2 (CH2); MS m/z (EI) 239 (M+., 21), 180 (11), 126 (17), 83 (74). HRMS calcd. for C12H17NO4: 239.1158; found: 239.1170.

4. Conclusions

We have developed a versatile synthetic approach to obtain [1,2]isoxazolidin-5-ones 3 in good yields and with total stereoselectivity. In addition, the method was used in the preparation of 4-functional heterocyclic compounds 4 in good overall yields.
Table 2

Methyl 2-alkyl-6-oxo-5,6-dihydro-2H-1,2-oxazine-4-carboxylate 4a-e prepared.

ProductRYield a (%)
4a iC3H779
4b tC4H976
4c cC6H1158
4d C6H535
4e CH2C6H56

Isolated yield after chromatography.

  9 in total

1.  N-Benzylhydroxylamine addition to beta-aryl enoates. Enantioselective synthesis of beta-aryl-beta-amino acid precursors

Authors: 
Journal:  Org Lett       Date:  2000-10-19       Impact factor: 6.005

2.  A new antitumor antibiotic, FR-66979.

Authors:  H Terano; S Takase; J Hosoda; M Kohsaka
Journal:  J Antibiot (Tokyo)       Date:  1989-01       Impact factor: 2.649

3.  Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma.

Authors:  Masamichi Inami; Ikuo Kawamura; Susumu Tsujimoto; Fusako Nishigaki; Sanae Matsumoto; Yoshinori Naoe; Yuka Sasakawa; Masahiko Matsuo; Toshitaka Manda; Toshio Goto
Journal:  Cancer Lett       Date:  2002-07-08       Impact factor: 8.679

4.  Enantioselective conjugate addition of hydroxylamines to pyrazolidinone acrylamides.

Authors:  M P Sibi; M Liu
Journal:  Org Lett       Date:  2001-12-27       Impact factor: 6.005

5.  A synthetic library of cell-permeable molecules.

Authors:  K Koide; J M Finkelstein; Z Ball; G L Verdine
Journal:  J Am Chem Soc       Date:  2001-01-24       Impact factor: 15.419

6.  A novel synthesis of amino-1,2-oxazinones as a versatile synthon for beta-amino acid derivatives.

Authors:  Okiko Miyata; Megumi Namba; Masafumi Ueda; Takeaki Naito
Journal:  Org Biomol Chem       Date:  2004-04-14       Impact factor: 3.876

7.  Enantioselective synthesis of alpha,beta-disubstituted-beta-amino acids.

Authors:  Mukund P Sibi; Narayanasamy Prabagaran; Sandeep G Ghorpade; Craig P Jasperse
Journal:  J Am Chem Soc       Date:  2003-10-01       Impact factor: 15.419

8.  Asymmetric total synthesis and stereochemical elucidation of the antitumor agent PM-94128.

Authors:  Samir K Patel; Karine Murat; Sandrine Py; Yannick Vallée
Journal:  Org Lett       Date:  2003-10-30       Impact factor: 6.005

9.  FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.

Authors:  Y Naoe; M Inami; S Matsumoto; F Nishigaki; S Tsujimoto; I Kawamura; K Miyayasu; T Manda; K Shimomura
Journal:  Cancer Chemother Pharmacol       Date:  1998       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.